Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 19/20 | 0.64 |
| ▸ | ITGA5 | P08648 | 18/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 14/20 | 0.64 |
| ▸ | ITGAV | P06756 | 14/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4070620 | 0.95 | ITGB1 (0.70) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4068227 | 0.93 | ITGB1 (0.63) | ITGB1ITGA5ITGB3ITGAVITGA4 | |
| SCHEMBL4073721 | 0.88 | ITGB1 (0.59) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4931046 | 0.88 | ITGB1 (0.83) | ITGB1ITGA5ITGB3ITGAVL3MBTL1 | |
| SCHEMBL4068188 | 0.87 | ITGB1 (0.70) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4743659 | 0.87 | ITGB1 (0.54) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4066312 | 0.85 | ITGB1 (0.65) | ITGB1ITGA5ITGB3ITGAVITGA4 | |
| SCHEMBL4066315 | 0.83 | ITGB1 (0.90) | ITGB1ITGA5ITGB3ITGAV | |
| SCHEMBL4069743 | 0.83 | ITGB1 (0.58) | ITGB1ITGA5ITGB3ITGAVITGA4 | |
| SCHEMBL4787748 | 0.82 | ITGB1 (0.63) | ITGB1ITGA5ITGB3ITGAVITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049490-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | Astra Zeneca AB (SE) | 2009-04-22 | — | — | EP | claimed |
| WO-2007141473-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | ASTRAZENECA AB (SE) | 2007-12-13 | — | — | WO | claimed |
| EP-2049490-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | Astra Zeneca AB (SE) | 2009-04-22 | — | — | EP | disclosed |
| WO-2007141473-A1 | N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS | ASTRAZENECA AB (SE) | 2007-12-13 | — | — | WO | disclosed |